FreeMind Investments
Funding rounds backed by FreeMind Investments.
- Funding disclosed in full
- $20M
- Median round
- $20M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| General Proximity Develops induced proximity medicines targeting undruggable proteins across oncology and cardiometabolic disease | $20MStrategic | BiotechUnited States |